StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs
An uptick in initial public offering (IPO) filings in recent weeks suggests that the market for first-time biotech stocks is finally recovering after three years of sparse activity capped by share prices that had fallen from the highs of coming to market …